Twin Tree Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.9M | Sell |
97,300
-356,000
| -79% | -$20.8M | 0.12% | 188 |
|
|
2025
Q4 | $24.5M | Sell |
453,300
-168,400
| -27% | -$8.1M | 0.21% | 101 |
|
|
2025
Q3 | $28M | Buy |
621,700
+393,500
| +172% | +$18.4M | 0.12% | 202 |
|
|
2025
Q2 | $10.6M | Buy |
228,200
+105,100
| +85% | +$5.16M | 0.02% | 753 |
|
|
2025
Q1 | $7.51M | Sell |
123,100
-1,539,800
| -93% | -$89.8M | 0.01% | 769 |
|
|
2024
Q4 | $94.1M | Buy |
1,662,900
+665,900
| +67% | +$37.2M | 0.17% | 104 |
|
|
2024
Q3 | $51.6M | Buy |
997,000
+105,200
| +12% | +$4.94M | 0.1% | 159 |
|
|
2024
Q2 | $37M | Sell |
891,800
-191,800
| -18% | -$8.58M | 0.08% | 217 |
|
|
2024
Q1 | $58.8M | Buy |
1,083,600
+1,009,600
| +1,364% | +$51.4M | 0.13% | 148 |
|
|
2023
Q4 | $3.8M | Buy |
+74,000
| New | +$3.88M | 0.01% | 938 |
|
|
2022
Q4 | – | Sell |
-145,100
| Closed | -$10.3M | – | 1300 |
|
|
2022
Q3 | $10.3M | Sell |
145,100
-543,900
| -79% | -$39.5M | 0.02% | 549 |
|
|
2022
Q2 | $53.1M | Buy |
689,000
+253,300
| +58% | +$19.3M | 0.08% | 166 |
|
|
2022
Q1 | $31.8M | Sell |
435,700
-426,200
| -49% | -$28.6M | 0.05% | 320 |
|
|
2021
Q4 | $53.7M | Buy |
861,900
+502,200
| +140% | +$29.5M | 0.11% | 150 |
|
|
2021
Q3 | $21.3M | Hold |
359,700
| – | – | 0.05% | 349 |
|
|
2021
Q2 | $24M | Buy |
+359,700
| New | +$23.5M | 0.06% | 298 |
|
|
2020
Q4 | – | Sell |
-620,600
| Closed | -$37.4M | – | 1277 |
|
|
2020
Q3 | $37.4M | Buy |
620,600
+209,200
| +51% | +$12.6M | 0.15% | 143 |
|
|
2020
Q2 | $24.2M | Hold |
411,400
| – | – | 0.1% | 240 |
|
|
2020
Q1 | $22.9M | Buy |
411,400
+182,600
| +80% | +$11.2M | 0.11% | 169 |
|
|
2019
Q4 | $14.7M | Sell |
228,800
-631,900
| -73% | -$36.2M | 0.05% | 278 |
|
|
2019
Q3 | $43.6M | Buy |
860,700
+472,800
| +122% | +$22.2M | 0.17% | 85 |
|
|
2019
Q2 | $17.6M | Buy |
387,900
+363,800
| +1,510% | +$16.9M | 0.09% | 203 |
|
|
2019
Q1 | $1.15M | Sell |
24,100
-201,000
| -89% | -$10M | 0.01% | 798 |
|
|
2018
Q4 | $11.7M | Buy |
225,100
+29,100
| +15% | +$1.56M | 0.07% | 281 |
|
|
2018
Q3 | $12.2M | Buy |
196,000
+41,200
| +27% | +$2.44M | 0.08% | 210 |
|
|
2018
Q2 | $8.57M | Buy |
154,800
+53,300
| +53% | +$2.88M | 0.05% | 302 |
|
|
2018
Q1 | $6.42M | Buy |
+101,500
| New | +$6.53M | 0.05% | 293 |
|
|
2017
Q3 | – | Sell |
-142,600
| Closed | -$7.95M | – | 980 |
|
|
2017
Q2 | $7.95M | Sell |
142,600
-255,800
| -64% | -$13.9M | 0.06% | 285 |
|
|
2017
Q1 | $21.7M | Buy |
398,400
+210,700
| +112% | +$11.6M | 0.2% | 113 |
|
|
2016
Q4 | $11M | Buy |
187,700
+154,200
| +460% | +$8.43M | 0.11% | 223 |
|
|
2016
Q3 | $1.81M | Sell |
33,500
-20,500
| -38% | -$1.32M | 0.02% | 518 |
|
|
2016
Q2 | $3.97M | Sell |
54,000
-5,700
| -10% | -$403K | 0.06% | 315 |
|
|
2016
Q1 | $3.81M | Buy |
59,700
+58,000
| +3,412% | +$3.66M | 0.07% | 279 |
|
|
2015
Q4 | $117K | Sell |
1,700
-3,400
| -67% | -$225K | ﹤0.01% | 1184 |
|
|
2015
Q3 | $302K | Sell |
5,100
-34,000
| -87% | -$2.16M | 0.01% | 900 |
|
|
2015
Q2 | $2.6M | Buy |
39,100
+14,300
| +58% | +$942K | 0.06% | 324 |
|
|
2015
Q1 | $1.6M | Buy |
24,800
+19,300
| +351% | +$1.21M | 0.04% | 456 |
|
|
2014
Q4 | $325K | Sell |
5,500
-24,500
| -82% | -$1.38M | 0.01% | 841 |
|
|
2014
Q3 | $1.53M | Sell |
30,000
-193,100
| -87% | -$9.65M | 0.04% | 456 |
|
|
2014
Q2 | $10.8M | Buy |
223,100
+25,200
| +13% | +$1.24M | 0.24% | 63 |
|
|
2014
Q1 | $10.3M | Buy |
+197,900
| New | +$10.5M | 0.21% | 79 |
|
|
2013
Q4 | – | Sell |
-100,000
| Closed | -$4.63M | – | 932 |
|
|
2013
Q3 | $4.63M | Sell |
100,000
-15,300
| -13% | -$672K | 0.16% | 134 |
|
|
2013
Q2 | $5.15M | Buy |
+115,300
| New | +$5.01M | 0.2% | 83 |
|
Other funds holding BMY
VCM
VPM
Twin Tree Management's BMY Position: Q1 2026 in Review
Twin Tree Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 356,621 shares — an estimated $20.8M sold.
Twin Tree Management first reported a position in BMY in Q4 2013 and held it in 34 quarters. The position peaked at $24.3M in Q2 2022. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Twin Tree Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
- Twin Tree Management sold 356,621 Bristol-Myers Squibb shares in Q1 2026, an estimated $20.8M.
- Twin Tree Management first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 34 quarters.
- Twin Tree Management's Bristol-Myers Squibb position peaked at $24.3M in Q2 2022.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Twin Tree Management's 13F filing for Q1 2026, filed 14 May 2026.